Results 241 to 250 of about 1,274,843 (306)

A Panel of VHH Antibodies Against Sabin Type 1 Poliovirus D-Antigen Reveals Strain-Specific and Cross-Serotype Reactivity. [PDF]

open access: yesViruses
Ermakova M   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Monoclonal Antibodies: A Review

Current Clinical Pharmacology, 2018
Over the last three decades, monoclonal antibodies (MAbs) have made a striking transformation from scientific tools to powerful human therapeutics. Muromonab CD3 a murine MAb was the first FDA approved therapeutic MAb for the prevention of kidney transplant rejection.
Jaykaran Charan
exaly   +3 more sources

Monoclonal Antibodies

Journal of Infectious Diseases, 1981
Serologic reagents have played an important role in the diagnosis, treatment, and epidemiology of infectious diseases. A new technology has been developed for generating homogeneous antibodies that can be produced in large amounts and are available indefinitely. This technique promises to increase the reliability and sensitivity of immunoassays and may
M D, Scharff, S, Roberts, P, Thammana
openaire   +4 more sources

Monoclonal Antibodies

2008
Monoclonal antibodies (mabs) are powerful tools for the quantification, detection, and targeting of specific molecules. Allergen-specific mabs are important for the quantification of major allergens in allergen preparations used for allergen-specific immunotherapy and allergy diagnosis.
Helga, Kahlert, Oliver, Cromwell
openaire   +2 more sources

Monoclonal Rh antibodies

Revue Francaise de Transfusion et Immuno-hématologie, 1988
The Rh antibodies were studied by manual serological techniques (see Daniels' report on Kell related antigens), using human red cells of common and rare Rh phenotypes in an attempt to identify their specificity and/or usefulness as reagents. The report is divided into 3 sections : section I anti-D antibodies, section II other Rh specifities, section ...
P, Tippett, C, Lomas
openaire   +2 more sources

Monoclonal antibodies in myeloma. [PDF]

open access: possibleClinical advances in hematology & oncology : H&O, 2015
The development of monoclonal antibodies (mAbs) for the treatment of disease goes back to the vision of Paul Ehrlich in the late 19th century; however, the first successful treatment with a mAb was not until 1982, in a lymphoma patient. In multiple myeloma, mAbs are a very recent and exciting addition to the therapeutic armamentarium. The incorporation
Sondergeld, P.   +3 more
openaire   +4 more sources

Monoclonal antibodies and arthritis

Agents and Actions, 1990
Monoclonal antibodies to certain cell surface constituents on lymphocytes, monocytes and macrophages have been administered to Lewis rats with developing, established or adoptively transferred arthritis, to determine any immunomodulatory properties.
M E, Billingham, C, Hicks, S, Carney
openaire   +2 more sources

Home - About - Disclaimer - Privacy